Veerhealth Care is currently trading at Rs. 20.02, up by 0.01 points or 0.05% from its previous closing of Rs. 20.01 on the BSE.
The scrip opened at Rs. 19.85 and has touched a high and low of Rs. 20.50 and Rs. 19.85 respectively. So far 6138 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 27.00 on 26-Jul-2024 and a 52 week low of Rs. 9.29 on 04-Mar-2025.
Last one week high and low of the scrip stood at Rs. 21.20 and Rs. 19.31 respectively. The current market cap of the company is Rs. 40.04 crore.
The promoters holding in the company stood at 31.50%, while non-institutions held 68.50% stake in the company.
Veerhealth Care has entered into a strategic contract manufacturing agreement with a company having top position in personal care segment on marketplace companies in the country for the production of its private-label personal care range of products.
Under the terms of the agreement, the company will manufacture and supply personal care range of products exclusively tailored to the company's brand specifications and quality standards. The company is in the process of regulatory approval which is expected to be completed soon and commercial production is expected to begin soon. This development is expected to have a positive impact on the company's revenue and capacity utilization in the coming quarters.
Veerhealth Care is engaged mainly in business of trading and manufacturing and marketing research based ayurvedic medicines.
| Company Name | CMP |
|---|---|
| Redington | 234.90 |
| Adani Enterprises | 2218.35 |
| Amrapali Industries | 17.53 |
| Rashi Peripheral | 455.25 |
| PDS | 301.45 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: